Russell Investments Group’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-187,922
Closed -$1.14M 4333
2025
Q4
$1.14M Sell
187,922
-41,193
-18% -$375K ﹤0.01% 2156
2025
Q3
$2.52M Buy
229,115
+8,499
+4% +$75.3K ﹤0.01% 1742
2025
Q2
$1.54M Buy
+220,616
New +$1.34M ﹤0.01% 1853
2022
Q3
Sell
-3,439
Closed -$19K 2986
2022
Q2
$19K Hold
3,439
﹤0.01% 2805
2022
Q1
$27K Buy
+3,439
New +$29.6K ﹤0.01% 2666
2021
Q4
Sell
-26,288
Closed -$357K 3125
2021
Q3
$357K Sell
26,288
-2,504
-9% -$33.3K ﹤0.01% 2593
2021
Q2
$430K Sell
28,792
-59,627
-67% -$914K ﹤0.01% 2660
2021
Q1
$1.55M Buy
88,419
+86,410
+4,301% +$1.54M ﹤0.01% 2019
2020
Q4
$25K Sell
2,009
-25,289
-93% -$357K ﹤0.01% 2971
2020
Q3
$295K Sell
27,298
-51,302
-65% -$661K ﹤0.01% 2619
2020
Q2
$973K Sell
78,600
-25,489
-24% -$345K ﹤0.01% 2069
2020
Q1
$1.65M Sell
104,089
-10,526
-9% -$209K ﹤0.01% 1564
2019
Q4
$2.91M Buy
114,615
+52,059
+83% +$926K 0.01% 1520
2019
Q3
$967K Buy
+62,556
New +$1.01M ﹤0.01% 2020

Other funds holding XGN

Russell Investments Group's XGN Position: Q1 2026 in Review

Russell Investments Group sold out of Exagen (XGN) in Q1 2026, closing a stake of 187,922 shares — an estimated $1.14M sold.

Russell Investments Group first reported a position in XGN in Q3 2019 and held it in 14 quarters. The position peaked at $2.91M in Q4 2019. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Russell Investments Group reported no remaining Exagen position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 187,922 Exagen shares in Q1 2026, an estimated $1.14M.
  • Russell Investments Group first reported a position in Exagen in Q3 2019 and held it in 14 quarters.
  • Russell Investments Group's Exagen position peaked at $2.91M in Q4 2019.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.